BioReliance Introduces Advanced In Vitro ADME And Toxicology Services Designed To Improve Drug Safety And Efficacy
October 16, 2014 at 07:10 AM EDT
BioReliance® (www.bioreliance.com), Sigma-Aldrich Corporation's (NASDAQ: SIAL) biologics and early-development services business under ...